CoChat

Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial

Mello, Rodrigo P., Echegaray, Mariana V.F., Jesus-Nunes, Ana Paula, Leal, Gustavo C., Magnavita, Guilherme M., Vieira, Flávia, Caliman-Fontes, Ana Teresa, Telles, Manuela, Guerreiro-Costa, Lívia N.F., Souza-Marques, Breno, Bandeira, Igor D., Santos-Lima, Cassio, Marback, Roberta F., Correia-Melo, Fernanda S., Lacerda, Acioly L.T., Quarantini, Lucas C. · 2021 · Journal of Psychiatric Research
Cited by 21

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Dissociative symptoms are common, possibly severe, side effects associated with the use of ketamine and esketamine in depression. We investigated the relationship between trait dissociation and dissociation induced by ketamine and esketamine used as augmentation therapy in treatment-resistant depression (TRD). Adults with TRD were randomly assigned to receive a single intravenous infusion, with a duration of 40 min, of either esketamine 0.25 mg/kg or ketamine 0.5 mg/kg. We assessed trait dissociation with the Dissociative Experience Scale (DES) and, to evaluate induced dissociation, the Clinician-Administered Dissociative States Scale (CADSS) was used. Thirty-two subjects received esketamine and 29 received ketamine. The groups had similar median DES scores (p = 0.26). More than 30% of the patients in both groups had DES scores ≥30 points. The median CADSS score in the esketamine group was equivalent to that in the ketamine group (p = 0.40). Every 5 points increment in the DES was associated with a 10.9% (95% CI 4.5-17.8%) increase in the CADSS, in an exponential fashion when the two groups were pooled together. Subjects with high trait dissociation had a higher risk of induced dissociation state (relative risk [RR] 1.41, 95% CI 1.11-1.78) and very high induced dissociation (RR 3.05, 95% CI 1.14-8.15). Induced dissociation was not a serious adverse effect. The findings suggest that trait dissociation is a predictor of induced dissociation by Ketamine or Esketamine in TRD subjects. Screening for trait dissociation and counseling patients with high trait dissociation on the risks of dissociation by these drugs are recommended.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jpsychires.2021.05.014

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Research works printed but not linked: 36

  1. Acevedo-Diaz, 2020, Can ‘floating’ predict treatment response to ketamine? Data from three randomized trials of individuals with treatment-resistant depression, J. Psychiatr. Res., 130, 280, 10.1016/j.jpsychires.2020.06.012 · DOI
  2. Administration, 2019, Psychopharmacologic drugs advisory committee (PDAC) and drug safety and risk management (DSaRM) advisory committee meeting, Advis. Comm. Meet. 2019
  3. Ajub, 2018, Efficacy of esketamine in the treatment of depression with psychotic features: a case series, Biol. Psychiatr., 83, e15, 10.1016/j.biopsych.2017.06.011 · DOI
  4. Amorim, 2000, Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais, Rev. Bras. Psiquiatr., 22, 106, 10.1590/S1516-44462000000300003 · DOI · Paper page
  5. Ballard, 2020, Neurobiological research with suicidal participants: a framework for investigators, Gen. Hosp. Psychiatr., 62, 43, 10.1016/j.genhosppsych.2019.11.007 · DOI
  6. Berman, 2000, Antidepressant effects of ketamine in depressed patients, Biol. Psychiatr., 47, 351, 10.1016/S0006-3223(99)00230-9 · DOI · Paper page
  7. Bernstein, 1986, Development, reliability, and validity of a dissociation scale, J. Nerv. Ment. Dis., 174, 727, 10.1097/00005053-198612000-00004 · DOI · Paper page
  8. Carlson, 1993, An update on the dissociative experiences scale, Dissociation, 6, 16
  9. Castle, 2017, Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders, J. Psychopharmacol., 31, 1306, 10.1177/0269881117725685 · DOI
  10. Černis, 2020, Dissociation in relation to other mental health conditions: an exploration using network analysis: dissociation across mental health, J. Psychiatr. Res., 136, 460, 10.1016/j.jpsychires.2020.08.023 · DOI
  11. Cooper, 2017, Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review, World J. Biol. Psychiatr., 18, 410, 10.3109/15622975.2016.1139747 · DOI · Paper page
  12. Correia-Melo, 2017, Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review, Neuropsychiatric Dis. Treat., 13, 1627, 10.2147/NDT.S135623 · DOI · Paper page
  13. Correia-Melo, 2018, Comparative study of esketamine and racemic ketamine in treatment-resistant depression: protocol for a non-inferiority clinical trial, Med. (United States), 97
  14. Correia-Melo, 2017, S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression, Rev. Bras. Psiquiatr., 39, 188, 10.1590/1516-4446-2016-2070 · DOI
  15. Fekadu, 2009, A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method, J. Clin. Psychiatr., 70, 177, 10.4088/JCP.08m04309 · DOI · Paper page
  16. Fiszman, 2004, A adaptação transcultural para o português do instrumento dissociative experiences scale para rastrear e quantificar os fenômenos dissociativos, Rev. Bras. Psiquiatr., 26, 164, 10.1590/S1516-44462004000300006 · DOI
  17. Gómez-Pérez, 2013, Predictors of trait dissociation and peritraumatic dissociation induced via cold pressor, Psychiatr. Res., 210, 274, 10.1016/j.psychres.2013.06.001 · DOI
  18. Leonard, 1999, Dissociation in the laboratory: a comparison of strategies, Behav. Res. Ther., 37, 49, 10.1016/S0005-7967(98)00072-2 · DOI
  19. Lipsanen, 2004, Exploring the relations between depression, somatization, dissociation and alexithymia--overlapping or independent constructs?, Psychopathology, 37, 200, 10.1159/000080132 · DOI · Paper page
  20. Longden, 2020, The relationship between dissociation and symptoms of psychosis: a meta-analysis, Schizophr. Bull., 46, 1104, 10.1093/schbul/sbaa037 · DOI · Paper page
  21. Messer, 2010, Maintenance ketamine treatment produces long-term recovery from depression, Prim. Psychiatr., 17, 48
  22. Montgomery, 1979, A new depression scale designed to be sensitive to change, Br. J. Psychiatry, 134, 382, 10.1192/bjp.134.4.382 · DOI · Paper page
  23. Niciu, 2018, Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression, J. Affect. Disord., 232, 310, 10.1016/j.jad.2018.02.049 · DOI · Paper page
  24. Nunes, 2018, Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - a case series, Schizophr. Res., 202, 394, 10.1016/j.schres.2018.06.034 · DOI
  25. Ozer, 2003, Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis, Psychol. Bull., 129, 52, 10.1037/0033-2909.129.1.52 · DOI · Paper page
  26. Pennybaker, 2017, Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion, J. Affect. Disord., 208, 560, 10.1016/j.jad.2016.10.026 · DOI · Paper page
  27. Petersen, 2005, Empirical testing of two models for staging antidepressant treatment resistance, J. Clin. Psychopharmacol., 25, 336, 10.1097/01.jcp.0000169036.40755.16 · DOI · Paper page
  28. Petrakis, 2004, Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism, Am. J. Psychiatr., 161, 1776, 10.1176/ajp.161.10.1776 · DOI · Paper page
  29. Poerio, 2016, Tracking potentiating states of dissociation: an intensive clinical case study of sleep, daydreaming, mood, and depersonalization/derealization, Front. Psychol., 7, 1231, 10.3389/fpsyg.2016.01231 · DOI
  30. Singh, 2016, Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study, Biol. Psychiatr., 80, 424, 10.1016/j.biopsych.2015.10.018 · DOI · Paper page
  31. Swainson, 2021, The Canadian network for mood and anxiety treatments (CANMAT) task force recommendations for the use of racemic ketamine in adults with major depressive disorder: recommandations du groupe de travail du réseau canadien pour les traitements de L’humeur et, Can. J. Psychiatr., 66, 113, 10.1177/0706743720970860 · DOI · Paper page
  32. van Heugten-Van der Kloet, 2015, MDMA, cannabis, and cocaine produce acute dissociative symptoms, Psychiatr. Res., 228, 907, 10.1016/j.psychres.2015.04.028 · DOI
  33. van Huijstee, 2018, The dissociative subtype of post-traumatic stress disorder: research update on clinical and neurobiological features, Curr. Top. Behav. Neurosci., 38, 229, 10.1007/7854_2017_33 · DOI
  34. Zarate, 2006, A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression, Arch. Gen. Psychiatr., 63, 856, 10.1001/archpsyc.63.8.856 · DOI · Paper page
  35. Zhang, 2014, R (-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine, Pharmacol. Biochem. Behav., 116, 137, 10.1016/j.pbb.2013.11.033 · DOI · Paper page
  36. Zoellner, 2007, Dissociation and serenity induction, J. Behav. Ther. Exp. Psychiatr., 38, 252, 10.1016/j.jbtep.2006.06.003 · DOI

Cited by

See all 21

Metadata

Authors
Mello, R. P., Echegaray, M. V. F., Jesus-Nunes, A. P., Leal, G. C., Magnavita, G. M., Vieira, F., Caliman-Fontes, A. T., Telles, M., Guerreiro-Costa, L. N. F., Souza-Marques, B., Bandeira, I. D., Santos-Lima, C., Marback, R. F., Correia-Melo, F. S., Lacerda, A. L. T., & Quarantini, L. C.
Venue
Journal of Psychiatric Research
Publisher
Elsevier BV
Published
2021-06
Volume
138
Pages
576-583
ISSN
0022-3956 (ISSN-L)
OpenAlex
W3162004623
Cited by
21
References
20
FWCI
1.66
Type
journal article
Language
en
Open access
closed
Funders
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial. https://app.cochat.ai/papers/10.1016/j.jpsychires.2021.05.014
The paper
Mello, R. P., Echegaray, M. V. F., Jesus-Nunes, A. P., Leal, G. C., Magnavita, G. M., Vieira, F., Caliman-Fontes, A. T., Telles, M., Guerreiro-Costa, L. N. F., Souza-Marques, B., Bandeira, I. D., Santos-Lima, C., Marback, R. F., Correia-Melo, F. S., Lacerda, A. L. T., & Quarantini, L. C. (2021). Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial. Journal of Psychiatric Research. https://doi.org/10.1016/j.jpsychires.2021.05.014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.